Ligand Pharmaceuticals Inc
LGND· Nasdaq
LGNDLigand Pharmaceuticals Inc
Filed May 11, 2015 · 10-Q · 41 days after period end · 0000886163-15-000062
| Metric | Q1 2015 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $14.60M | $5.64M | $3.90M |
| Net Income | $754.00K | $1.13M | $9.63M |
| EPS Diluted | $0.04 | $0.06 | $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end
